BSE - Free Realtime Quote INR

Akums Drugs and Pharmaceutical (AKUMS.BO)

559.15
+2.75
+(0.49%)
As of 9:35:54 AM GMT+5:30. Market Open.
Loading Chart for AKUMS.BO
  • Previous Close 556.40
  • Open 555.95
  • Bid 557.95 x --
  • Ask 559.20 x --
  • Day's Range 554.55 - 560.70
  • 52 Week Range 407.40 - 1,174.85
  • Volume 1,609
  • Avg. Volume 34,090
  • Market Cap (intraday) 86.453B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 25.00
  • EPS (TTM) 22.37
  • Earnings Date Aug 22, 2025 - Aug 23, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 750.00

Akums Drugs and Pharmaceuticals Limited manufactures and sells pharmaceutical products and active pharmaceutical ingredients India and internationally. It offers dosage forms, such as tablets, hard and soft gelatin capsules, liquid orals, sachets, vials, ampoules, form fill seals, topical preparations, eye drops, dry powder injections, rotacaps and gummies, and others. The company operates as pharmaceutical contract development and manufacturing company. It also sells branded pharmaceutical formulations. The company was incorporated in 2004 and is based in Delhi, India.

www.akums.in

--

Full Time Employees

March 31

Fiscal Year Ends

Recent News: AKUMS.BO

Más detalles

Performance Overview: AKUMS.BO

Trailing total returns as of 6/5/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .

YTD Return

AKUMS.BO
12.37%
S&P BSE SENSEX (^BSESN)
4.17%

1-Year Return

AKUMS.BO
22.88%
S&P BSE SENSEX (^BSESN)
9.43%

3-Year Return

AKUMS.BO
22.88%
S&P BSE SENSEX (^BSESN)
45.95%

5-Year Return

AKUMS.BO
22.88%
S&P BSE SENSEX (^BSESN)
137.39%

Comparar con: AKUMS.BO

Puedes seleccionar hasta 4 acciones para analizar empresas similares utilizando métricas clave de rendimiento.

Statistics: AKUMS.BO

Más detalles

Valuation Measures

Annual
As of 6/3/2025
  • Market Cap

    86.03B

  • Enterprise Value

    80.66B

  • Trailing P/E

    24.86

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.09

  • Price/Book (mrq)

    2.82

  • Enterprise Value/Revenue

    1.96

  • Enterprise Value/EBITDA

    15.13

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    8.21%

  • Return on Assets (ttm)

    5.03%

  • Return on Equity (ttm)

    18.17%

  • Revenue (ttm)

    41.18B

  • Net Income Avi to Common (ttm)

    3.38B

  • Diluted EPS (ttm)

    22.37

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    5.76B

  • Total Debt/Equity (mrq)

    2.88%

  • Levered Free Cash Flow (ttm)

    984.94M

Research Analysis: AKUMS.BO

Más detalles

Company Insights: AKUMS.BO

Reportes de investigación: AKUMS.BO

Más detalles

People Also Watch